Acelyrin Inc (SLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SLRN | ALLO | FHTX | ||
| Company | Acelyrin Inc | Allogene Therapeutics Inc | Foghorn Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.26 | 2.15 | 8.00 | ||
| High | 4.51 | 2.15 | 8.25 | ||
| Low | 4.24 | 2.15 | 7.70 | ||
| Last | 4.33 | 2.15 | 7.72 | ||
| Change | -0.10 | +0.04 | -0.14 | ||
| % Change | -2.26% | +1.89% | -1.78% | ||
| Volume | 338,000 | 7,893 | 70,500 | ||
| 20-Day Average Volume | 484,420 | 2,555,915 | 130,315 | ||
| Previous Close | 4.43 | 2.11 | 7.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.57 | 2.64 | 8.39 | ||
| 20-Day Raw Stochastic | 4.02% | 10.95% | 16.46% | ||
| 20-Day Relative Strength | 36.03% | 39.17% | 45.34% | ||
| Weighted Alpha | -55.62 | -37.85 | -3.10 | ||
| Today's Opinion | 24% Sell | 72% Sell | 48% Buy | ||
| Previous Opinion | 24% Sell | 72% Sell | 48% Buy | ||
| Last Month's Opinion | 24% Buy | 48% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.09% since 11/14/24 | -5.73% since 11/15/24 | -12.27% since 11/14/24 | ||
| Low | 4.24 on 11/21/24 | 1.99 on 11/20/24 | 7.33 on 11/15/24 | ||
| High | 5.19 on 11/15/24 | 2.32 on 11/18/24 | 8.79 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -29.94% since 10/21/24 | -23.57% since 10/22/24 | +6.78% since 10/21/24 | ||
| Low | 4.24 on 11/21/24 | 1.99 on 11/20/24 | 7.14 on 10/22/24 | ||
| High | 6.48 on 11/06/24 | 3.36 on 11/07/24 | 9.70 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | -9.79% since 08/21/24 | -17.37% since 08/22/24 | +4.32% since 08/21/24 | ||
| Low | 4.16 on 09/09/24 | 1.99 on 11/20/24 | 6.94 on 10/10/24 | ||
| High | 6.52 on 10/17/24 | 3.36 on 11/07/24 | 10.25 on 09/20/24 | ||
| 6-Month | |||||
| %Chg | unch since 05/21/24 | -19.55% since 05/22/24 | +24.12% since 05/21/24 | ||
| Low | 3.36 on 08/14/24 | 1.99 on 11/20/24 | 4.77 on 07/10/24 | ||
| High | 7.25 on 07/17/24 | 3.67 on 07/16/24 | 10.25 on 09/20/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 434,412 | 442,408 | 429,178 | ||
| Shares Outstanding, K | 100,326 | 209,672 | 55,593 | ||
| Annual Sales | 0 | 100,000 | 34,160,000 | ||
| Annual Net Income | -381,640,000 | -327,270,000 | -98,430,000 | ||
| Last Quarter Sales | 0 | 0 | 7,810,000 | ||
| Last Quarter Net Income | -48,550,000 | -66,360,000 | -19,120,000 | ||
| 60-Month Beta | 1.98 | 0.84 | 3.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 11/13/24 | -0.27 on 11/07/24 | -0.31 on 11/04/24 | ||
| Latest Earnings Date | 11/13/24 | 11/07/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||